AI Drug-Design Startup Chai Discovery Raises $400M Series C
Chai Discovery, an AI startup that designs antibodies and other molecules from scratch, raised a $400 million Series C led by Index Ventures at a $3.8 billion valuation.
Read more →AI in Biologyand AI in Business
Every AI News story tagged with both AI in Biology and AI in Business — the two topics side by side, updated as new articles publish.
1 article